In most cases, human gene transfer research is no longer novel or controversial enough to require additional review from the National Institutes of Health's Recombinant DNA Advisory Committee, known as RAC, says a new report ...
Dec 5, 2013
0
0
Cancer immunotherapy can successfully use the body's own immune system to kill tumor cells. But some current approaches to stimulate an antitumor immune response are short-lived, with limited clinical effectiveness. A new ...
Oct 9, 2013
0
0
The receptor used by baculovirus to enter and interact with human cells has been identified. This syndecan–1 receptor was identified for the first time in a recent collaborative study carried out by the University of Eastern ...
Sep 27, 2013
0
0
(Medical Xpress)—Researchers at Iowa State University have identified a genetic process by which some Escherichia coli bacteria adapt to the human kidney, a step that could lead to new treatments to stop urinary tract infections.
Aug 23, 2013
0
0
Bacterial DNA may integrate into the human genome more readily in tumors than in normal human tissue, according to a new study from the University of Maryland School of Medicine's Institute for Genome Sciences. Researchers ...
Jun 20, 2013
0
0
European scientists have made a major breakthrough in the treatment of inherited retinal diseases.
Jun 20, 2013
0
0
Stent angioplasty saves lives, but there often are side effects and complications related to the procedure, such as arterial restenosis and thrombosis. In the June 2013 issue of The FASEB Journal, however, scientists report ...
May 30, 2013
0
0
Scientists at the Academy of Finland's Centre of Excellence in Computational Inference Research have developed novel computational methods that have yielded essential knowledge of how hospital-acquired bacteria spread and ...
Jan 16, 2013
0
0
(Medical Xpress)—Humans may have acquired enzymes that make blood groups from bacteria to hinder the spread of viruses in the population, suggests a study led by scientists at the University of Bath.
Dec 19, 2012
0
0
Nine of twelve leukemia patients who received infusions of their own T cells after the cells had been genetically engineered to attack the patients' tumors responded to the therapy, which was pioneered by scientists in the ...
Dec 10, 2012
0
0
